NASDAQ:KARD Kardigan (KARD) Stock Price, News & Analysis $11.49 -1.03 (-8.23%) As of 11/20/2026 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Kardigan Stock (NASDAQ:KARD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Kardigan alerts:Sign Up Key Stats Today's Range$11.49▼$12.7750-Day Range$11.49▼$19.0552-Week Range$11.49▼$27.00Volume459,244 shsAverage Volume497,709 shsMarket Capitalization$1.08 billionP/E RatioN/ADividend YieldN/APrice Target$41.00Consensus RatingModerate Buy Company Overview Kardigan is a biopharmaceutical company focused on developing medicines for cardiovascular diseases. Its work centers on advancing therapeutic candidates intended to address heart and vascular conditions. The company’s activities include research and development of a pipeline of cardiovascular drug candidates. Kardigan was launched as a biotechnology company in 2024; detailed information about its commercial products and geographic operations is limited.AI Generated. May Contain Errors. Read More Kardigan Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks47th Percentile Overall ScoreKARD MarketRank™: 2.340157038695 of 5 starsKardigan scored higher than 47% of companies evaluated by MarketBeat, and ranked 523rd out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingModerate Buy Consensus RatingKardigan has received a consensus rating of Moderate Buy. The company's average rating score is 2.90, and is based on 2 strong buy ratings, 6 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialKardigan has a consensus price target of $41.00, representing about 256.8% upside from its current price of $11.49.Amount of Analyst CoverageKardigan has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Kardigan's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Kardigan are expected to decrease in the coming year, from ($3.39) to ($3.85) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Kardigan is -3.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Kardigan is -3.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioKardigan has a P/B Ratio of 1.88. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.09% of the float of Kardigan has been sold short.Short Interest Ratio / Days to CoverKardigan has a short interest ratio ("days to cover") of 11.19, which indicates bearish sentiment.Change versus previous monthShort interest in Kardigan has recently increased by 7.38%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldKardigan does not currently pay a dividend.Dividend GrowthKardigan does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.23 News SentimentKardigan has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Kardigan this week, compared to 3 articles on an average week.Search Interest2 people have searched for KARD on MarketBeat in the last 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Kardigan insiders have not sold or bought any company stock.Percentage Held by InstitutionsKardigan has minimal institutional ownership at this time.Read more about Kardigan's insider trading history. Receive KARD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kardigan and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KARD Stock News HeadlinesKardigan (NASDAQ:KARD) Stock Rating Raised to "Hold" at Wall Street ZenNovember 21 at 1:18 AM | americanbankingnews.comHC Wainwright Analysts Raise Earnings Estimates for KardiganNovember 16, 2026 | americanbankingnews.comA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.November 22 at 1:00 AM | Profits Run (Ad)Kardigan Q3 Net Loss FallsNovember 12, 2026 | marketscreener.comMKardigan, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 12, 2026 | marketscreener.comMKardigan Reports Third Quarter 2026 Financial Results and Recent Business UpdatesNovember 12, 2026 | marketscreener.comMKardigan: Q3 earnings snapshotNovember 12, 2026 | msn.comTranscript : Kardigan, Inc. - Special CallNovember 7, 2026 | marketscreener.comMSee More Headlines KARD Stock Analysis - Frequently Asked Questions How have KARD shares performed this year? Kardigan's stock was trading at $22.00 on June 18, 2026. Since then, KARD stock has decreased by 47.8% and is now trading at $11.49. How were Kardigan's earnings last quarter? Kardigan, Inc. (NASDAQ:KARD) issued its quarterly earnings results on Thursday, November, 12th. The company reported ($0.64) EPS for the quarter, topping the consensus estimate of ($0.80) by $0.16. When did Kardigan IPO? Kardigan (KARD) raised $400 million in an initial public offering (IPO) on Thursday, June 18th 2026. The company issued 25,000,000 shares at $16.00 per share. When does the company's lock-up period expire? Kardigan's lock-up period expires on Tuesday, December 15th. Kardigan had issued 25,000,000 shares in its initial public offering on June 18th. The total size of the offering was $400,000,000 based on an initial share price of $16.00. After the end of the company's lock-up period, major shareholders and company insiders will be able to sell their shares of the company. Who are Kardigan's major shareholders? Top institutional investors of Kardigan include Goldman Sachs Group Inc. (0.58%), State Street Corp (0.49%), Integral Health Asset Management LLC (0.24%) and Jump Financial LLC (0.02%). Insiders that own company stock include Paul L Berns and Arch Venture Partners Xiii, Ll. View institutional ownership trends. How do I buy shares of Kardigan? Shares of KARD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/12/2026Today11/22/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:KARD CIK2123613 Webwww.kardigan.bio Phone415-573-3220FaxN/AEmployees241Year FoundedN/APrice Target and Rating Average Price Target for Kardigan$41.00 High Price Target$50.00 Low Price Target$25.00 Potential Upside/Downside+256.8%Consensus RatingModerate Buy Rating Score (0-4)2.90 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)($3.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$191.94 million Net MarginsN/A Pretax MarginN/A Return on Equity-152.99% Return on Assets-46.19% Debt Debt-to-Equity RatioN/A Current Ratio10.62 Quick Ratio10.62 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$6.12 per share Price / Book1.88Miscellaneous Outstanding Shares93,600,000Free FloatN/AMarket Cap$1.08 billion OptionableOptionable BetaN/A 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:KARD) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersPrediction: NVDA will “snap back” on this dateOthers paid $500 for the Snapback Indicator. For Black Friday, Base Camp Trading is offering lifetime access f...Base Camp Trading | SponsoredYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredNoah’s Ark found?Scientists may have discovered Noah's Ark buried under a mountain in eastern Turkey, just two miles from the I...Brownstone Research | Sponsored“IMPERIUM”: The #1 investment of 2027Could a strange new bio-chip be the most transformative innovation in history? Elon Musk calls it "amazing." A...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kardigan, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kardigan With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.